Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Crinetics Pharmaceuticals (CRNX)

Crinetics Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRNX
DateTimeSourceHeadlineSymbolCompany
11/03/202520:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
10/03/202520:36GlobeNewswire Inc.Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CRNXCrinetics Pharmaceuticals Inc
05/03/202521:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
27/02/202521:23Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRNXCrinetics Pharmaceuticals Inc
27/02/202521:13Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRNXCrinetics Pharmaceuticals Inc
27/02/202521:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
27/02/202521:05GlobeNewswire Inc.Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateNASDAQ:CRNXCrinetics Pharmaceuticals Inc
24/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
24/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
24/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
24/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
24/02/202513:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
24/02/202513:30GlobeNewswire Inc.Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial OfficerNASDAQ:CRNXCrinetics Pharmaceuticals Inc
20/02/202521:05GlobeNewswire Inc.Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor ConferencesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
10/02/202521:44GlobeNewswire Inc.Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CRNXCrinetics Pharmaceuticals Inc
06/02/202521:35GlobeNewswire Inc.Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025NASDAQ:CRNXCrinetics Pharmaceuticals Inc
05/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
03/02/202521:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
29/01/202521:30Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
29/01/202521:30Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
14/01/202522:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
13/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
10/01/202522:15GlobeNewswire Inc.Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CRNXCrinetics Pharmaceuticals Inc
10/01/202512:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
10/01/202512:00GlobeNewswire Inc.Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)NASDAQ:CRNXCrinetics Pharmaceuticals Inc
07/01/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
06/01/202513:00GlobeNewswire Inc.Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CRNXCrinetics Pharmaceuticals Inc
30/12/202421:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
18/12/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
16/12/202421:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CRNX